* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Summary of methods to assess mRNA stability in eukaryotic cells
Cell encapsulation wikipedia , lookup
Extracellular matrix wikipedia , lookup
Organ-on-a-chip wikipedia , lookup
Cellular differentiation wikipedia , lookup
Signal transduction wikipedia , lookup
Cell nucleus wikipedia , lookup
List of types of proteins wikipedia , lookup
Gene expression wikipedia , lookup
Biologia molecolare - Robert F. Weaver Copyright © 2005 – The McGraw-Hill Companies srl Summary of methods to assess mRNA stability in eukaryotic cells Method Advantage Disadvantage Comments Pulse-chase labeling with 3H-U measurement of "true" chemical half life low sensitivity for high abundance, slow turnover mRNAs Injection of in vitro transcribed 32PRNA measurement of "true" chemical half life lack of cellular RNA modifications, labour intensive oocytes can differ from somatic cells, Inducible promoter relatively rapid induction induction may alter cell physiology Hsp70 and myc promoter Pharmacological transcription block can be applied to all genes, rapid onset block perturbation of cellular metabolism, Actinomycin D, and DRB most commonly used Comparison of transcription rate and steady state mRNA level can be applied to all genes, useful screening procedure mRNA stability is not directly measured should only be used in combination with another method In vitro RNA degradation easy, identification of intermediates, purification of transacting factors difficult to establish physiological relevance and specificity must be established mRNA degradative activities in mammalian cells Decapping • DCP2 which binds RNA as a prerequisite for cap recognition. • DCP1 augments DCP2 activity • LSM (SM-LIKE) PROTEINS augment DCP2 activity 5’ -to-3’ exonuclease activity • XRN1 is a proven 5’ -to-3’ exonuclease that localizes to the cytoplasm. • RAT1/XRN2 is only thought to be a 5’ -to-3’ exonuclease on the basis of its similarity to the yeast orthologue. Deadenylation • PARN is one of five mammalian homologues to yeast Caf1/Pop2 protein 3’ -to-5’ exonuclease activity • Exosome (six RNase-PH-DOMAIN components, PM/SCL75,MTR3,RRP41, RRP42, RRP43 and RRP46; three S1 and KH RNA-binding components,RRP4, RRP40 and CSL4; the RNASE D-like components PM/SCL100; the putative helicaseKIAA0053; and a protein that is phosphorylated in the M phase of the cell) PMR1-like activity • Polysomal ribonuclease 1 (PMR1) is a polysome-associated mRNA endonuclease ARE-binding proteins Protein kDa Motif Expression site ARE Function AUF1 37,40,42,45 RRM Ubiquitous c-myc, c-fos, GM-CSF mRNA destab. AUBF ND ND T cells c-fos, INF, IL-3 v-myc, GMCSF, (AUUUA)n ARE-binding corr. with mRNA stab. AU-A 34 ND T cells TNF, GM-CSF, c-myc ND AU-B 30 AU-C 43 hnRNPA1 36 RRM Human PBMCs GM-CSF, IL-2, c-myc ND hnRNPC 43 Elav-like 36–40 RRM Ubiquitous, nervous system c-myc, c-fos,TNF-a,GM-CSF mRNA stab. 40, 42 RRM Brain, spleen, lung, liver,testis TNF, GM-CSF Transl. inhib. HuR HuD HuC Hel-N1 TIAR Brain, spleen, testis TIA-1 TTP 44 Cys3His Fibroblasts, macrophages TNF, IL-3 GM-CSF mRNA destab. KSRP 78 KH Neural cells and other types c-fos mRNA destab. •AUBF, AU binding factor ; AU-A, AU binding factor-A ; AU-B, AU binding factor-B ; AU-C, AU binding factor-C ; hnRNP, heterogeneous nuclear ribonucleoprotein ; KH, hnRNP-K homology domain; KSRP, KH-type splicing regulatory protein 1; ND, not determined; PBMC, peripheral blood mononuclear cell.